Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02192775 · FLOW

Participant flow

UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus · Source last updated 2020-10-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    MV-NIS: one dose in conjunction with a 4 day course intravenously
    id
    FG000
    title
    MV-NIS + Cyclophosphamide
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        2
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        2
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    MV-NIS: one dose in conjunction with a 4 day course intravenously
    id
    FG000
    title
    MV-NIS + Cyclophosphamide
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        2
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        2
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice